Necrotizing Enterocolitis (NEC) lawsuits target manufacturers of cow’s milk-based infant formulas, such as Enfamil and Similac, alleging that these products increase the risk of NEC in premature infants. Plaintiffs claim that companies like Abbott Laboratories and Mead Johnson failed to warn about the risks, leading to severe health complications or death.
NEC is a serious intestinal condition that can cause severe damage, requiring surgery or leading to long-term health issues. Common symptoms include abdominal swelling, feeding difficulties, and bloody stools.
Families may be eligible to file an NEC lawsuit if their premature infant developed necrotizing enterocolitis after being fed cow’s milk-based formulas like Enfamil or Similac in a hospital NICU. Eligibility typically requires a confirmed NEC diagnosis, supported by medical records, and documented use of the formula, often shown through hospital or pharmacy records.
Plaintiffs allege that manufacturers knew or should have known about the link between their formulas and NEC but failed to provide adequate warnings. Claims must be filed within the statute of limitations, which varies by state but is typically one to three years from diagnosis or discovery of the link. Over 700 cases are consolidated in a federal multidistrict litigation (MDL-3026), with bellwether trials scheduled for 2025 and 2026.
For more information or to discuss your eligibility, complete the form to the right.